Background: Radiolabeled metaiodobenzylguanidine (MIBG) is sensitive and specific for detecting neuroblastoma. The extent of MIBG-avid disease is assessed using Curie scores. Although Curie scoring is prognostic in patients with high-risk neuroblastoma, there is no standardized method to assess the response of specific sites of disease over time. The goal of this study was to develop approaches for Curie scoring to facilitate the calculation of scores and comparison of specific sites on serial scans.
INTRODUCTION
Neuroblastoma is an embryonal tumor of the sympathetic nervous system responsible for 15% of pediatric cancer deaths in the United States. 1 It displays genetic and clinical heterogeneity. Based on clinical and biologic variables, patients are assigned to risk groups and treatment regimens. 2 Despite excellent outcomes for some, survival remains poor for high-risk patients despite intensive, multimodal therapies. [3] [4] [5] Survival has been shown to be superior for those who respond to induction therapy. 6-9 123 I-MIBG whole-body scintigraphy is a powerful imaging technique for detecting neuroblastoma and evaluating treatment response.
The current standard in the Children's Oncology Group (COG) for comparing successive 123 I-MIBG scans to assess treatment response is the Curie method, 10 as detailed in a recent consensus report from the International Neuroblastoma Risk Group (INRG) Task Force. 11 The scoring algorithm divides the body into nine skeletal sections with a tenth soft-tissue section. The 10 sections are graded for extent of MIBG avidity on a 0 to 3 scale: 0 = no involvement, 1 = one site, 2 = more than one site, 3 = diffuse involvement (>50% of the segment). This method is considered "semi-subjective." The Curie score is the sum of all 10 segments. Serial patient Curie scores are compared to assess treatment response.
Matthay et al reported significantly worse outcomes for patients with total Curie scores >2 following induction chemotherapy compared with those with scores of ≤2. 6, 12 Subsequent analyses determined that Curie scores >2 after induction but not at diagnosis in patients enrolled on a high-risk COG study were associated with significantly worse event-free survival (EFS). 7 There was no correlation between Curie score at diagnosis and survival. More recently, in an International Society of Pediatric Oncology European Network (SIOPEN) high-risk study, researchers were able to validate that patients with a Curie score of ≤2 postinduction have significantly better EFS. 13 Although the prognostic value of Curie scores has not yet been validated in high-risk patients receiving current COG standard treatment including tandem stem cell transplants and immunotherapy following induction, MIBG relative scores on bone sectors have been integrated into the recent revision of the International Neuroblastoma Response Criteria (INRC). 14 The relative bone score is the ratio of the Curie scores at response assessment to diagnosis (without the softtissue component). Resolution of MIBG activity defines a complete response. A partial response is defined as a reduction of 50% or greater in MIBG bone score. Reduction by less than 50% is stable disease. Any new lesion represents progressive disease.
Although the prognostic significance of Curie scores has been established, the manual methods currently used to calculate total scores do not provide mechanisms to longitudinally track specific lesions or easily compare regions of diffuse involvement over time.
Often, only the total Curie score is provided in the MIBG report by the imaging physician, without documentation of the specific lesions and sites of disease. We hypothesized that by integrating a computerized user interface and automation, Curie scores would be more accurately quantified and documented for longitudinal review. To test this hypothesis, we designed three semiautomated methods to calculate Curie scores with increasing degrees of computer assistance. A survey was administered to evaluate the imaging physicians' opinions regarding the feasibility and utility of each method in clinical practice. The aim of the study was to compare the three methods to determine: (1) the efficiency of each method for determining Curie scores; (2) the variance of Curie scores between readers; and (3) the feasibility of tracking specific MIBG-positive lesions over time.
METHODS

Patient cohort
Patients with neuroblastoma and available MIBG scans were identified through The University of Chicago and COG. Institutional review board approval was obtained to collect imaging and clinical information from patients at the University of Chicago. Consents were obtained from patients available to consent, and a waiver was granted for patients unavailable to consent. Deidentified scans were also obtained from the Quality Assurance Review Center (QARC) through COG under a data use agreement with the University of Chicago.
The use of these scans was additionally given a waiver of consent.
Participating imaging physicians also signed research consents to collect data surrounding their use of the methods and their survey information.
MIBG semiquantitative Curie scoring
Three semiautomated mechanisms to calculate Curie scores were 
Method B: Computer-assisted Curie scores
In method B, the imaging physicians marked the lesion locations on the images and then indicated the corresponding Curie segment by clicking a schematic figure. The score of each segment (0, 1, 2, or 3) was automatically computed ( 
Method C: Computer-assisted Curie scores
In method C, the imaging physician defined a Curie anatomic segment region map or "mesh" on the patient images by specifying key anatomic points that corresponded to points shown on a skeleton schematic ( Fig. 3A and 3B ; Supporting Information Figure S2 ), making adjustments to the region map as necessary by dragging the intersecting handles between the segments (Fig. 3C ). An anterior image mesh defined seven of the nine skeletal regions, and a smaller posterior image mesh defined the other two skeletal regions corresponding to the spine. The ability to manipulate the mesh is especially useful in children, as there may not be uniformity in anatomic landmarks identified by the mesh generation software. The imaging physician could then mark lesions in either image (as points, lines, or loops), except that spine lesions were required to be marked in the posterior image, while medial rib, sternum, and pelvic lesions were required to be marked in the anterior image, in order to be assigned to the proper anatomic segment.
Based on location, each lesion mark was automatically assigned to the corresponding Curie anatomic region, and scores were adjusted by the system without requiring additional effort from the imaging physician. A key difference between the methods B and C is that in the latter, the imaging physician need not click on the schematic to assign an anatomic segment to a lesion. Rather, the lesion's position within the region map automatically determined its anatomic segment. The lesions could be specified at any time during a case, before or after the region map itself was specified, and the region map could likewise be modified as needed. 
Survey
An 18-question survey was administered to characterize ease-ofuse, clinical utility, and potential adoption of each of the methods (Supporting Information Figure S1 ). The secure REDCap survey was administered via e-mail to all participating imaging physicians and was completed by all five imaging physicians. 
Statistical analysis
RESULTS
Patient cohort
Thirty-four patients from the University of Chicago with available MIBG scans were enrolled on this study. Additionally, MIBG scans from 4 patients were obtained from QARC for analysis. All patients had a diagnosis of neuroblastoma except for one with metastatic paraganglioma (Supporting Information Table S1 ). Twenty-seven University of Chicago patients had metastatic disease. The patients ranged in age from 6 weeks to 22 years (median 3 years). Eleven scans were obtained at initial diagnosis, ten during or after induction chemotherapy, three during or prior to immunotherapy, one at end of therapy, and nine during therapy for relapsed disease. The four patients with scans obtained through QARC have unknown clinical information.
F I G U R E 3
A, In method C, the radiologist first indicates key points that will define the region map ("mesh"). The radiologist clicks on 9-11 points on the anterior image (in blue) that correspond to the points shown on the skeleton image in the upper right corner of the screen, with the left elbow and left fingertip points being optional. B, After the radiologist specifies the key points, the region map ("mesh") is created, which outlines the Curie anatomic segments for this case, and the radiologist can then adjust the region map if necessary by moving the circular handles between each anatomic segment. C, After the mesh has been created, the radiologist can draw lesions (as points, lines, or loops), and the system automatically assigns anatomic segments and scores based on drawn lesion locations. See Supporting Information Figure S2 for text in the figure
Curie scoring 4.2.1 Reliability between methods
We first wanted to study whether the same observer obtained similar results using methods A, B, and C. All MIBG scans were scored by each imaging physician using all three methods (Supporting Information These data suggest excellent reliability across methods. The poorest reliability existed in regions seven (the lower arms) and region ten (soft tissue) but even these showed substantial reliability across methods.
Interobserver reliability
We then calculated the reliability among observers for each method.
Interobserver reliability was calculated using weighted Fleiss' kappa statistics to show consistency between the imaging physicians ( Table 2 ). The kappa statistic was first calculated assuming that all Curie regions were of similar reliability and was 0.840 for method A, 0.811 for method B, and 0.804 for method C, demonstrating excellent reliability between observers. We then evaluated by Curie region and found kappa statistics ranging from 0.743 to 0.933 for method A, from 0.699 to 0.918 for method B, and from 0.728 to 0.901 for method C.
Overall interobserver reliability is excellent, similar to intraobserver reliability.
Time analysis
On average, reading scans with method B took 72% longer than with method A. Method C took 141% longer than method A and 68% longer than method B. For method A, the time for scoring each scan ranged Table S3 ). On average, method B took 57 seconds longer per scan than method A, and method C took 53 seconds longer than method B, and 110 seconds longer than method A.
TA B L E 2 Comparison of scores between observers
Physician assessment of the Curie scoring methods
All five participating imaging physicians completed the survey (Supporting Information Table S4 ). The imaging physicians noted how likely they would be to utilize each method (method A MIBG score >4 following induction was also associated with inferior outcome. 8 These studies highlight the prognostic importance of MIBG scoring. The current manual method of determining Curie scores limits the ability to longitudinally monitor specific lesions or regional disease in a standardized manner. We hypothesized that by integrating computational techniques, Curie scores would be more reliably quantified and specific sites of disease could be accurately assessed for response.
These semiautomated methods represent the first step toward making Curie scoring more consistent. Further automation may be achieved via the process previously reported at the University of Chicago with Tc-99m bone scans. 16, 17 A computer-aided diagnostic approach was designed to identify differences in scans from multiple time points using a nonlinear image warping technique. Shiraishi et al created a computational algorithm involving image density normalization and downstream processing to successfully identify new and resolved lesions over time. This method was subsequently found to be beneficial 84.6% of the time and has the potential to significantly aid in the evaluation of Tc-99 bone scans. Although bone scans are no longer used in patients with neuroblastoma, a similar approach could be applied to MIBG scans to help identify very subtle changes in metastatic disease patterns, thus making this modality more quantitative and leading to a more precise prognostication method for children with neuroblastoma. Future versions of the computer-assisted methods will need to adjust for improvements in technology, including SPECT imaging.
To bring these methods to clinical practice, the method must be validated in a larger study by comparing scores obtained using semiautomated scoring to scores given by consensus review of expert readers.
A prospective study can be used to determine the feasibility of using a semiautomated method in regular clinical practice. Ultimately, broad utilization of these methods could help to standardize the application of Curie scores and aid in monitoring the response of MIBG-avid neuroblastoma over time.
